{"id":"NCT01513239","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"A Study of MK-6072 and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-002)","officialTitle":"A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of a Single Infusion of MK-6072 (Human Monoclonal Antibody to Clostridium Difficile Toxin B), and MK-3415A (Human Monoclonal Antibodies to Clostridium Difficile Toxin A and B) in Patients Receiving Antibiotic Therapy for Clostridium Difficile Infection (MODIFY II)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-02-01","primaryCompletion":"2015-05-22","completion":"2015-05-22","firstPosted":"2012-01-20","resultsPosted":"2016-12-15","lastUpdate":"2018-09-05"},"enrollment":1203,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Clostridium Difficile Infection"],"interventions":[{"type":"BIOLOGICAL","name":"MK-6072","otherNames":[]},{"type":"BIOLOGICAL","name":"MK-3415A","otherNames":[]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"SOC","otherNames":[]}],"arms":[{"label":"MK-6072 + SOC","type":"EXPERIMENTAL"},{"label":"MK-3415A + SOC","type":"EXPERIMENTAL"},{"label":"Placebo + SOC","type":"PLACEBO_COMPARATOR"}],"summary":"MK-3415A is the combination of monoclonal antibodies to Clostridium (C.) difficile toxin A (MK-3415) and toxin B (MK-6072). This study will investigate whether: 1) treatment with MK-6072 or MK-3415A in addition to standard of care (SOC) antibiotic therapy will decrease Clostridium Difficile Infection (CDI) recurrence compared with placebo; and 2) MK-6072 and MK-3415A will be generally well tolerated in participants receiving SOC therapy for CDI compared with placebo.","primaryOutcome":{"measure":"Percentage of Participants With CDI Recurrence","timeFrame":"12 weeks","effectByArm":[{"arm":"MK-3415A + SOC","deltaMin":14.9,"sd":null},{"arm":"MK-6072 + SOC","deltaMin":15.7,"sd":null},{"arm":"Placebo + SOC","deltaMin":25.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG001 vs OG002","p":"0.0003"},{"comp":"OG000 vs OG001","p":"0.3718"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":15},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["36906440","36661328","32504314","32376702","32101275","32099847","31883370","31846705","31628838","31411386","30460321","30455246","30227108","30060024","29788418","29538686","28121498"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":118,"n":390},"commonTop":["Diarrhoea","Nausea","Clostridium difficile infection","Neutrophil count increased","Lymphocyte count decreased"]}}